はてなブックマーク

We've funded more than 500 portfolio companies across all stages and sectors, with an emphasis on enterprise, life sciences, consumer, and frontier technology. View our portfolio

Ben Robbins is Our Newest General Partner By: Krishna Yeshwant & David Schenkein July 28, 2022 One of the little-known secrets of GV's life sciences team is that none of us had dreams of becoming an investor. Everyone came in as a physician, scientist, or operator with aspirations to move the healthcare system forward. As a group, we want to change how healthcare is delivered, make drug delivery s

The sprint gives teams a shortcut to learning without building and launching. The sprint is a five-day process for answering critical business questions through design, prototyping, and testing ideas with customers. Developed at GV, it’s a “greatest hits” of business strategy, innovation, behavior science, design thinking, and more—packaged into a battle-tested process that any team can use. Worki

We've funded more than 500 portfolio companies across all stages and sectors, with an emphasis on enterprise, life sciences, consumer, and frontier technology. View our portfolio

Introducing Learn More Faster: How to Find Your Bullseye Customer and Their Perfect Product